Lazard Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,410
| Closed | -$90K | – | 2280 |
|
|
2024
Q1 | $90K | Hold |
4,410
| – | – | ﹤0.01% | 1573 |
|
|
2023
Q4 | $94K | Sell |
4,410
-6,451
| -59% | -$138K | ﹤0.01% | 1681 |
|
|
2023
Q3 | $223K | Buy |
10,861
+5,916
| +120% | +$121K | ﹤0.01% | 1354 |
|
|
2023
Q2 | $145K | Buy |
4,945
+2,025
| +69% | +$59.4K | ﹤0.01% | 1441 |
|
|
2023
Q1 | $67K | Sell |
2,920
-2,433
| -45% | -$55.8K | ﹤0.01% | 1687 |
|
|
2022
Q4 | $148K | Hold |
5,353
| – | – | ﹤0.01% | 1372 |
|
|
2022
Q3 | $164K | Hold |
5,353
| – | – | ﹤0.01% | 1316 |
|
|
2022
Q2 | $157K | Buy |
+5,353
| New | +$157K | ﹤0.01% | 1348 |
|
|
2021
Q4 | – | Sell |
-1,186
| Closed | -$59K | – | 2322 |
|
|
2021
Q3 | $59K | Buy |
+1,186
| New | +$59K | ﹤0.01% | 1601 |
|
|
2021
Q2 | – | Sell |
-833
| Closed | -$47K | – | 1985 |
|
|
2021
Q1 | $47K | Buy |
+833
| New | +$47K | ﹤0.01% | 1453 |
|
|
2020
Q1 | – | Sell |
-1,073
| Closed | -$18K | – | 1611 |
|
|
2019
Q4 | $18K | Buy |
+1,073
| New | +$18K | ﹤0.01% | 1254 |
|